BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

846 related articles for article (PubMed ID: 26440666)

  • 1. Arctigenin Suppress Th17 Cells and Ameliorates Experimental Autoimmune Encephalomyelitis Through AMPK and PPAR-γ/ROR-γt Signaling.
    Li W; Zhang Z; Zhang K; Xue Z; Li Y; Zhang Z; Zhang L; Gu C; Zhang Q; Hao J; Da Y; Yao Z; Kong Y; Zhang R
    Mol Neurobiol; 2016 Oct; 53(8):5356-66. PubMed ID: 26440666
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Adiponectin Suppresses T Helper 17 Cell Differentiation and Limits Autoimmune CNS Inflammation via the SIRT1/PPARγ/RORγt Pathway.
    Zhang K; Guo Y; Ge Z; Zhang Z; Da Y; Li W; Zhang Z; Xue Z; Li Y; Ren Y; Jia L; Chan KH; Yang F; Yan J; Yao Z; Xu A; Zhang R
    Mol Neurobiol; 2017 Sep; 54(7):4908-4920. PubMed ID: 27514756
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A novel human truncated IL12rβ1-Fc fusion protein ameliorates experimental autoimmune encephalomyelitis via specific binding of p40 to inhibit Th1 and Th17 cell differentiation.
    Guo W; Wang C; Wang X; Luo C; Yu D; Wang Y; Chen Y; Lei W; Gao X; Yao W
    Oncotarget; 2015 Oct; 6(30):28539-55. PubMed ID: 26384304
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dehydrodiconiferyl alcohol (DHCA) modulates the differentiation of Th17 and Th1 cells and suppresses experimental autoimmune encephalomyelitis.
    Lee J; Choi J; Lee W; Ko K; Kim S
    Mol Immunol; 2015 Dec; 68(2 Pt B):434-44. PubMed ID: 26477735
    [TBL] [Abstract][Full Text] [Related]  

  • 5. IFN-β regulates Th17 differentiation partly through the inhibition of osteopontin in experimental autoimmune encephalomyelitis.
    Zhao Q; Cheng W; Xi Y; Cao Z; Xu Y; Wu T; Li C; Niu X; Chen G
    Mol Immunol; 2018 Jan; 93():20-30. PubMed ID: 29127843
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Arctigenin exerts anti-colitis efficacy through inhibiting the differentiation of Th1 and Th17 cells via an mTORC1-dependent pathway.
    Wu X; Dou Y; Yang Y; Bian D; Luo J; Tong B; Xia Y; Dai Y
    Biochem Pharmacol; 2015 Aug; 96(4):323-36. PubMed ID: 26074264
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Presenilin1 regulates Th1 and Th17 effector responses but is not required for experimental autoimmune encephalomyelitis.
    Cummings M; Arumanayagam ACS; Zhao P; Kannanganat S; Stuve O; Karandikar NJ; Eagar TN
    PLoS One; 2018; 13(8):e0200752. PubMed ID: 30089166
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Arctigenin Exerts Neuroprotective Effect by Ameliorating Cortical Activities in Experimental Autoimmune Encephalomyelitis
    Wei L; Xue Z; Lan B; Yuan S; Li Y; Guo C; Zhang R; Ding R; Shen H
    Front Immunol; 2021; 12():691590. PubMed ID: 34349758
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CCDC134 ameliorated experimental autoimmune encephalomyelitis by suppressing Th1 and Th17 cells.
    Xia P; Gong X; Xiao L; Wang Y; Zhang T; Liao Q; Mo X; Qiu X; Huang J
    Brain Behav Immun; 2018 Jul; 71():158-168. PubMed ID: 29548993
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The flavonoid kurarinone inhibits clinical progression of EAE through inhibiting Th1 and Th17 cell differentiation and proliferation.
    Xie L; Gong W; Chen J; Xie HW; Wang M; Yin XP; Wu W
    Int Immunopharmacol; 2018 Sep; 62():227-236. PubMed ID: 30031314
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Korean Red Ginseng and Ginsenoside-Rb1/-Rg1 Alleviate Experimental Autoimmune Encephalomyelitis by Suppressing Th1 and Th17 Cells and Upregulating Regulatory T Cells.
    Lee MJ; Jang M; Choi J; Chang BS; Kim DY; Kim SH; Kwak YS; Oh S; Lee JH; Chang BJ; Nah SY; Cho IH
    Mol Neurobiol; 2016 Apr; 53(3):1977-2002. PubMed ID: 25846819
    [TBL] [Abstract][Full Text] [Related]  

  • 12. NFATc1 deficiency in T cells protects mice from experimental autoimmune encephalomyelitis.
    Reppert S; Zinser E; Holzinger C; Sandrock L; Koch S; Finotto S
    Eur J Immunol; 2015 May; 45(5):1426-40. PubMed ID: 25689841
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Simvastatin ameliorates experimental autoimmune encephalomyelitis by inhibiting Th1/Th17 response and cellular infiltration.
    de Oliveira DM; de Oliveira EM; Ferrari Mde F; Semedo P; Hiyane MI; Cenedeze MA; Pacheco-Silva A; Câmara NO; Peron JP
    Inflammopharmacology; 2015 Dec; 23(6):343-54. PubMed ID: 26559850
    [TBL] [Abstract][Full Text] [Related]  

  • 14. IFN-γ-Primed hUCMSCs Significantly Reduced Inflammation
    Ling X; Wang T; Han C; Wang P; Liu X; Zheng C; Bi J; Zhou X
    Front Immunol; 2022; 13():835345. PubMed ID: 35300342
    [TBL] [Abstract][Full Text] [Related]  

  • 15. BJ-1108, a 6-Amino-2,4,5-trimethylpyridin-3-ol analogue, regulates differentiation of Th1 and Th17 cells to ameliorate experimental autoimmune encephalomyelitis.
    Kang Y; Timilshina M; Nam TG; Jeong BS; Chang JH
    Biol Res; 2017 Feb; 50(1):8. PubMed ID: 28241881
    [TBL] [Abstract][Full Text] [Related]  

  • 16. 4-Ethylguaiacol modulates neuroinflammation and Th1/Th17 differentiation to ameliorate disease severity in experimental autoimmune encephalomyelitis.
    Weng WT; Kuo PC; Brown DA; Scofield BA; Furnas D; Paraiso HC; Wang PY; Yu IC; Yen JH
    J Neuroinflammation; 2021 May; 18(1):110. PubMed ID: 33975618
    [TBL] [Abstract][Full Text] [Related]  

  • 17. BJ-2266 ameliorates experimental autoimmune encephalomyelitis through down-regulation of the JAK/STAT signaling pathway.
    You Z; Timilshina M; Jeong BS; Chang JH
    Eur J Immunol; 2017 Sep; 47(9):1488-1500. PubMed ID: 28681958
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A natural flavonoid glucoside icariin inhibits Th1 and Th17 cell differentiation and ameliorates experimental autoimmune encephalomyelitis.
    Shen R; Deng W; Li C; Zeng G
    Int Immunopharmacol; 2015 Feb; 24(2):224-231. PubMed ID: 25528476
    [TBL] [Abstract][Full Text] [Related]  

  • 19. T-bet is essential for Th1-mediated, but not Th17-mediated, CNS autoimmune disease.
    O'Connor RA; Cambrook H; Huettner K; Anderton SM
    Eur J Immunol; 2013 Nov; 43(11):2818-23. PubMed ID: 23878019
    [TBL] [Abstract][Full Text] [Related]  

  • 20. IL-7/IL-7 Receptor Signaling Differentially Affects Effector CD4+ T Cell Subsets Involved in Experimental Autoimmune Encephalomyelitis.
    Arbelaez CA; Glatigny S; Duhen R; Eberl G; Oukka M; Bettelli E
    J Immunol; 2015 Sep; 195(5):1974-83. PubMed ID: 26223651
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 43.